TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged as a promising alternative for treating a compromised side branch. However, the benefit of DCBs in coronary bifurcations has not yet been fully established.

The aim of this study was to find out whether the use of DCBs vs non-compliant balloons (NCBs) might improve clinical outcomes in side branch stenting using the provisional stent technique.

Primary endpoint was a composite of target lesion failure (TLF), including cardiac death, target vessel myocardial infarction, and target vessel ischemia-driven revascularization. Secondary endpoints were the individual primary end components and stent thrombosis.

A total of 784 patients were randomized. 391 received DCBs and 393 NCBs. Mean patient age was 63, and they were mostly men. The most frequent clinical presentation was unstable angina, followed by non-ST segment elevation myocardial infarction (NSTEMI). The primary outcome was seen in 7.2% of DCB patients and 12.5% NCB patients (HR 0.56, 95% CI [0.65-0.88]; p = 0.013).

Read also: TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease.

There were no significant interactions at subgroup analysis, though greater benefits were seen in patients over 65 years and in bifurcations not involving the left main coronary artery.

Conclusions  

This study showed that the use of drug-coated balloons (DCBs) in the side branch, within the context of the provisional stenting, resulted in lower risk of target lesion failure (TLF) at 1-year follow-up vs non-compliant balloons (NCBs).

Original Title: Drug-coated balloon angioplasty for side branch during provisional stenting: the prospective, multicenter, randomized DCB-BIF Trial.

Reference: Shao-Liang Chen, MD et al TCT 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

RODIN-CUT: Successive Cutting Balloon Technique in Calcified Lesions

Moderate or severe coronary calcification can be a marker of poor prognosis in coronary artery disease, as it significantly increases the risk of failure...

Acute Coronary Syndrome with Multivessel Disease: Best Revascularization Strategy

The gold standard treatment for acute coronary syndrome (ACS), especially acute myocardial infarction (AMI) is primary angioplasty (PCI). However, 40 to 70% of ACS...

Improved Ejection Fraction in Chronic Total Occlusion?

Chronic total occlusions (CTO) represent a significant challenge in the current clinical practice, seeing as CTO percutaneous coronary intervention (PCI) is complex and involves...

Timing in Complete Revascularization in Acute Coronary Syndrome: BIOVASC 2-Year Followup

The concept of complete revascularization (CR) has been comprehensively studied, leading to diverse approaches and debates on optimal timing.  The BIOVASC trial explored the ideal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

RODIN-CUT: Successive Cutting Balloon Technique in Calcified Lesions

Moderate or severe coronary calcification can be a marker of poor prognosis in coronary artery disease, as it significantly increases the risk of failure...

Acute Coronary Syndrome with Multivessel Disease: Best Revascularization Strategy

The gold standard treatment for acute coronary syndrome (ACS), especially acute myocardial infarction (AMI) is primary angioplasty (PCI). However, 40 to 70% of ACS...

Improved Ejection Fraction in Chronic Total Occlusion?

Chronic total occlusions (CTO) represent a significant challenge in the current clinical practice, seeing as CTO percutaneous coronary intervention (PCI) is complex and involves...